ATC
JAZZ icon

Argent Trust Co’s Jazz Pharmaceuticals JAZZ Stock Holding History

Argent Trust Co’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
+918
New +$201K 0.01% 735

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Argent Trust Co's JAZZ Position: Q2 2026 in Review

Argent Trust Co opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2026: 918 shares worth $221K. The stake represents 0.01% of the portfolio and ranks #735 among its holdings.

643 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Argent Trust Co held 918 shares of Jazz Pharmaceuticals worth $221K as of Q2 2026.
  • Jazz Pharmaceuticals was a new Argent Trust Co position in Q2 2026.
  • Jazz Pharmaceuticals made up 0.01% of Argent Trust Co's portfolio in Q2 2026, its #735 holding.
  • 643 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Argent Trust Co's 13F filing for Q2 2026, filed 6 Aug 2026.